Financhill
Sell
46

CI Quote, Financials, Valuation and Earnings

Last price:
$312.39
Seasonality move :
1.76%
Day range:
$311.14 - $315.65
52-week range:
$262.03 - $370.83
Dividend yield:
1.86%
P/E ratio:
17.30x
P/S ratio:
0.34x
P/B ratio:
2.08x
Volume:
1.1M
Avg. volume:
1.8M
1-year change:
-6.41%
Market cap:
$83.5B
Revenue:
$244.4B
EPS (TTM):
$18.06

Earnings Data

Next earnings date for CI
Aug 01
2025
Most recent earnings per share
$4.85
Missed by $1.50
(May 2/2025)
Consensus Estimate
$6.35
(May 2/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/01/2025 Q2 $62.6B -- -- $7.13 --
05/02/2025 Q1 $60.4B $65.5B $4.85 $6.35 -$1.50
01/30/2025 Q4 $63.2B $65.7B $5.13 $7.82 -$2.69
10/31/2024 Q3 $59.6B $62.8B $2.63 $7.25 -$4.62
08/01/2024 Q2 $58.3B $60.5B $5.45 $6.42 -$0.97
05/02/2024 Q1 $56.6B $55.4B -$0.97 $6.22 -$7.19
02/02/2024 Q4 $48.9B $51.1B $3.49 $6.54 -$3.05
11/02/2023 Q3 $48.2B $49B $4.74 $6.68 -$1.94
08/03/2023 Q2 $47.2B $48.6B $4.92 $6.04 -$1.12
05/05/2023 Q1 $45.4B $46.5B $4.24 $5.24 -$1.00
02/03/2023 Q4 -- $45.8B $3.83 -- --
11/03/2022 Q3 -- $45.2B $8.97 -- --
08/04/2022 Q2 -- $45.4B $4.89 -- --
05/06/2022 Q1 -- $43.7B $3.73 -- --
02/03/2022 Q4 -- $45.7B $3.43 -- --
11/04/2021 Q3 -- $44.4B $4.80 -- --
08/05/2021 Q2 -- $43.2B $4.25 -- --
05/07/2021 Q1 -- $41B $3.30 -- --
02/16/2021 Q4 -- $41.9B $11.30 -- --
11/05/2020 Q3 -- $41B $3.78 -- --
07/30/2020 Q2 -- $39.3B $4.73 -- --
04/30/2020 Q1 -- $38.4B $3.15 -- --
02/06/2020 Q4 -- $38.3B $2.61 -- --
10/31/2019 Q3 -- $38.6B $3.57 -- --
08/01/2019 Q2 -- $38.8B $3.70 -- --
05/02/2019 Q1 -- $38B $3.56 -- --
02/01/2019 Q4 -- $14.3B $0.40 -- --
11/01/2018 Q3 -- $11.5B $3.14 -- --
08/02/2018 Q2 -- $11.5B $3.29 -- --
05/03/2018 Q1 -- $11.4B $3.72 -- --
02/01/2018 Q4 -- $10.7B $1.10 -- --
11/02/2017 Q3 -- $10.5B $2.21 -- --
08/04/2017 Q2 -- $10.4B $3.15 -- --
05/05/2017 Q1 -- $10.5B $2.30 -- --
02/02/2017 Q4 -- $10.3B $1.47 -- --
11/03/2016 Q3 -- $9.9B $1.76 -- --
08/04/2016 Q2 -- $10B $1.97 -- --
05/06/2016 Q1 -- $9.9B $2.00 -- --
02/04/2016 Q4 -- $9.5B $1.64 -- --
11/06/2015 Q3 -- $9.4B $2.10 -- --
07/30/2015 Q2 -- $9.5B $2.26 -- --

The Cigna Group Earnings Questions

  • How Much did The Cigna Group Generate in Revenue Last Quarter?

    The Cigna Group reported $65.5B worth of top line sales in its most recent quarter.

  • Did The Cigna Group Beat Earnings Last Quarter?

    The Cigna Group announced earnings per share of $4.85 which represents a miss of analyst forecast a $6.35 per share.

  • Is The Cigna Group Profitable?

    The Cigna Group reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for The Cigna Group EPS Next Year?

    The Cigna Group's earnings are forecast to grow from $12.12 per share to $28.51 per share next year representing an increase of 144.98%.

  • When is The Cigna Group's Earnings Date?

    The Cigna Group's next earnings date is August 1, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Reddit Stock Be In 5 Years?
Where Will Reddit Stock Be In 5 Years?

On a wet March morning last year, the famously orange…

Will Palantir Crash?
Will Palantir Crash?

AI and data analytics software major Palantir (NASDAQ:PLTR) has been…

Is Target’s Dividend Worth Buying?
Is Target’s Dividend Worth Buying?

Retail giant Target (NYSE:TGT) has been through an extremely volatile…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 41x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Sell
49
RGC alert for Jun 17

Regencell Bioscience Holdings [RGC] is up 30.47% over the past day.

Buy
79
ARQQ alert for Jun 18

Arqit Quantum [ARQQ] is up 6.36% over the past day.

Buy
59
SYM alert for Jun 17

Symbotic [SYM] is down 3.91% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock